BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cheng Y, Cheng Y, Liu X, Kang B, Tao W, Peng D. The Effect of Type 2 Diabetes Mellitus on the Short-Term Outcomes and Prognosis of Stage I–III Colorectal Cancer: A Propensity Score Matching Analysis. CMAR 2022;Volume 14:205-14. [DOI: 10.2147/cmar.s347242] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Liu D, Zhang X, Zhou H, Zhu Z, He Y, Wan X, Zhang B, Liu S, Liu L. Marked paper: Type 2 diabetes mellitus indicates increased postoperative complications and poor prognosis in colorectal cancer patients receiving curative surgery. Front Oncol 2023;13:1128383. [PMID: 36845740 DOI: 10.3389/fonc.2023.1128383] [Reference Citation Analysis]
2 Mosaad H, Shalaby S, Mahmoud NM, Ahmed MM, Fayed A, Ashour HR. LncRNA ANRIL promotes glucose metabolism and proliferation of colon cancer in a high-glucose environment and associated with worse outcome in diabetic colon cancer patients.. [DOI: 10.21203/rs.3.rs-2507997/v1] [Reference Citation Analysis]
3 Tan L, Li QS, Peng D, Cheng Y. Does PD-1 blockade play a decisive role in the pathological complete remission of unresectable MSS, BRAF V600E-mutated metastatic colorectal cancer: A case report. Front Oncol 2022;12:976622. [PMID: 36713544 DOI: 10.3389/fonc.2022.976622] [Reference Citation Analysis]
4 Zhang B, Liu XR, Liu XY, Kang B, Yuan C, Liu F, Li ZW, Wei ZQ, Peng D. The Impact of Serum Parameters Associated with Kidney Function on the Short-Term Outcomes and Prognosis of Colorectal Cancer Patients Undergoing Radical Surgery. Can J Gastroenterol Hepatol 2023;2023:2017171. [PMID: 36890805 DOI: 10.1155/2023/2017171] [Reference Citation Analysis]
5 Meng Q, Yu Y, Wang K, Zhang Z, Zhao J, Wang Y, Hao D, Wang G. The prognostic role of fasting plasma glucose levels on survival in advanced colorectal cancer patients with type II diabetes mellitus: a retrospective cohort study. J Gastrointest Oncol 2022;13:3080-9. [PMID: 36636046 DOI: 10.21037/jgo-22-1124] [Reference Citation Analysis]
6 Wen ZL, Zhou X, Xiao DC. Is red blood cell distribution width a prognostic factor for colorectal cancer? A meta-analysis. Front Surg 2022;9:945126. [PMID: 36263092 DOI: 10.3389/fsurg.2022.945126] [Reference Citation Analysis]
7 Tan L, Peng D, Cheng Y. Significant position of C-myc in colorectal cancer: a promising therapeutic target. Clin Transl Oncol 2022. [PMID: 35972682 DOI: 10.1007/s12094-022-02910-y] [Cited by in F6Publishing: 1] [Reference Citation Analysis]